Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction

NCT ID: NCT02484105

Last Updated: 2015-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Does comforting conversation during colonoscopy improve on patient satisfaction, compliance and pain management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Does comforting conversation during colonoscopy improve on patient satisfaction, compliance and pain management. A randomized controlled trial on comforting conversation or standard communication during colonoscopy. Using a mixed methods model, a qualitative study will be conducted to clarify what patients deem as important or effective conversation during colonoscopy. A randomized controlled trial will hereafter be conducted, where the results from the initial study will be utilized in the conversation during colonoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comforting Conversation

Conversation according to the initital qualitative study.

Group Type EXPERIMENTAL

Comforting Conversation

Intervention Type BEHAVIORAL

Pain management, distraction, diversion, empathy. Dependent on qualitative study results.

Standard Communication

Intervention Type BEHAVIORAL

Information on procedure type, duration, findings, key landmarks, possibility of analgesic treatment, pause in procedure.

Standard Communication

Standard information prior to and during endoscopy.

Group Type ACTIVE_COMPARATOR

Standard Communication

Intervention Type BEHAVIORAL

Information on procedure type, duration, findings, key landmarks, possibility of analgesic treatment, pause in procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comforting Conversation

Pain management, distraction, diversion, empathy. Dependent on qualitative study results.

Intervention Type BEHAVIORAL

Standard Communication

Information on procedure type, duration, findings, key landmarks, possibility of analgesic treatment, pause in procedure.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-85
* Colonoscopy
* Written informed content

Exclusion Criteria

* ASA Class 4 or higher
* BMI 40 or higher
* Analgesics taken prior to procedure
* Pregnancy or breast feeding
* Allergy to Fentanyl/Midazolam
* Daily consumption of opioids
* Unable to complete questionnaire
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jeppe Thue Jensen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeppe Thue Jensen

MD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Endoscopy, Gastrounit, Herlev Hospital

Herlev, Region H, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Peter Vilmann, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jakob Hendel, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-15001924

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Care for Colon 2015
NCT04049357 COMPLETED NA